Page last updated: 2024-08-23

methyldopa and Drug Withdrawal Symptoms

methyldopa has been researched along with Drug Withdrawal Symptoms in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-199028 (90.32)18.7374
1990's2 (6.45)18.2507
2000's0 (0.00)29.6817
2010's1 (3.23)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bar-Cohen, Y; Rivero, N; Su, JA; Tang, W1
Hubbell, FA; Weber, MA1
Kruger, SA; van der Merwe, CJ1
Houston, MC2
Cummings, DM; Vlasses, PH1
Johnson, JM1
Prichard, BN1
Conway, EL; Jarrott, B; Lewis, S; Louis, WJ; Summers, R1
Dackis, CA; Gold, MS; Washton, AM1
Fersel, J; Melman, A; Weinstein, P1
Garibova, TL; Voronina, TA1
Whitsett, TL1
Harris, DB; Stiff, JL1
Bune, AJ; Chalmers, JP; Graham, JR; Howe, PR; West, MJ; Wing, LM1
Sotaniemi, EA; Ylikallio, A1
Koch, HF; Webster, J1
Goldberg, AD; Raftery, EB; Wilkinson, P1
Eger, EI; Smith, M; Smith, RA; Winter, PM1
Campanini, T; Catalano, A; De Risio, C; Forino, V1
Frewin, DB; Penhall, RK1
McDevitt, DG; Scott, JN1
Dollery, CT1
Kosman, ME1
Alexander, CP; Burden, AC1
Fujita, T; Ono, A1
Holzgang, AJ; Labbate, LA1
Deneau, GA; Seevers, MH; Segal, M1
Bauer, GE; Lewis, RG; Maclachlan, I; Mitchell, AS; Raftos, J; Stokes, GS; Young, AA1
Gunne, LM1

Reviews

7 review(s) available for methyldopa and Drug Withdrawal Symptoms

ArticleYear
Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome.
    American heart journal, 1981, Volume: 102, Issue:3 Pt 1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bethanidine; Blood Pressure; Clonidine; Guanabenz; Heart Failure; Humans; Hypertension; Methyldopa; Myocardial Infarction; Pressoreceptors; Prospective Studies; Substance Withdrawal Syndrome; Syndrome; Time Factors

1981
Antihypertensive drug withdrawal syndrome.
    Drug intelligence & clinical pharmacy, 1982, Volume: 16, Issue:11

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Catecholamines; Clonidine; Humans; Methyldopa; Risk; Substance Withdrawal Syndrome

1982
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
    The Journal of nervous and mental disease, 1984, Volume: 172, Issue:3

    Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome

1984
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Drugs, 1984, Volume: 28 Suppl 2

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihypertensive Agents; Asthma; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney Failure, Chronic; Labetalol; Methyldopa; Parasympathetic Nervous System; Pheochromocytoma; Pregnancy; Pregnancy Complications, Cardiovascular; Substance Withdrawal Syndrome; Tetanus

1984
The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat.
    Clinical and experimental hypertension. Part A, Theory and practice, 1984, Volume: 6, Issue:1-2

    Topics: Animals; Blood Pressure; Brain; Clonidine; Heart Rate; Humans; Methyldopa; Rats; Receptors, Adrenergic, alpha; Sleep, REM; Substance Withdrawal Syndrome

1984
The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Advances in alcohol & substance abuse, 1984,Spring, Volume: 3, Issue:3

    Topics: Adult; Baclofen; Clonidine; Drug Therapy, Combination; Electric Stimulation Therapy; Endorphins; Ethanol; Female; Humans; Locus Coeruleus; Male; Methyldopa; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1984
Aspects of tolerability of centrally acting antihypertensive drugs.
    Journal of cardiovascular pharmacology, 1996, Volume: 27 Suppl 3

    Topics: Antihypertensive Agents; Clonidine; Humans; Imidazoles; Methyldopa; Reserpine; Substance Withdrawal Syndrome

1996

Trials

3 trial(s) available for methyldopa and Drug Withdrawal Symptoms

ArticleYear
The antihypertensive effect of guanfacine compared with methyldopa.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Mar-15, Volume: 57, Issue:11

    Topics: Adrenergic alpha-Agonists; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Guanfacine; Guanidines; Humans; Hypertension; Indoles; Isoindoles; Male; Methyldopa; Middle Aged; Phenylacetates; Pulse; Substance Withdrawal Syndrome; Sulfonamides; Time Factors

1980
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
    The Journal of nervous and mental disease, 1984, Volume: 172, Issue:3

    Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome

1984
Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.
    European journal of clinical pharmacology, 1981, Volume: 19, Issue:5

    Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Guanfacine; Guanidines; Humans; Hypertension; Methyldopa; Norepinephrine; Phenylacetates; Substance Withdrawal Syndrome

1981

Other Studies

22 other study(ies) available for methyldopa and Drug Withdrawal Symptoms

ArticleYear
Prenatal exposure to methyldopa leading to hypertensive crisis and cardiac failure in a neonate.
    Pediatrics, 2014, Volume: 133, Issue:5

    Topics: Adrenergic Agonists; Female; Heart Failure; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Newborn; Methyldopa; Pregnancy; Prenatal Exposure Delayed Effects; Substance Withdrawal Syndrome

2014
Adverse effects of sudden withdrawal of antihypertensive medication.
    Postgraduate medicine, 1980, Volume: 68, Issue:2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Drug Therapy, Combination; Humans; Methyldopa; Norepinephrine; Substance Withdrawal Syndrome; Sympathetic Nervous System; Syndrome

1980
Abrupt discontinuation of antihypertensive therapy.
    Southern medical journal, 1981, Volume: 74, Issue:9

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bethanidine; Clonidine; Drug Therapy, Combination; Humans; Hypertension; Methyldopa; Prospective Studies; Substance Withdrawal Syndrome

1981
Further studies on the effect of chronic alpha-methyldopa administration upon the central nervous system and sexual function in male rats.
    The Journal of urology, 1984, Volume: 132, Issue:4

    Topics: Animals; Carbidopa; Central Nervous System; Erectile Dysfunction; Humans; Libido; Male; Methyldopa; Norepinephrine; Penis; Rats; Reflex; Sexual Behavior, Animal; Substance Withdrawal Syndrome; Yohimbine

1984
Clonidine and methyldopa--any role for hypertension now?
    Drug and therapeutics bulletin, 1984, Jun-04, Volume: 22, Issue:11

    Topics: Clonidine; Humans; Hypertension; Methyldopa; Substance Withdrawal Syndrome

1984
[Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration].
    Biulleten' eksperimental'noi biologii i meditsiny, 1980, Volume: 89, Issue:7

    Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain; Dihydroxyphenylalanine; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Humans; Male; Methyldopa; Rats; Semicarbazides; Substance Withdrawal Syndrome; Valproic Acid

1980
Abrupt cessation of treatment with centrally acting antihypertensive agents. A review.
    Chest, 1983, Volume: 83, Issue:2 Suppl

    Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Humans; Hypertension; Methyldopa; Renin-Angiotensin System; Substance Withdrawal Syndrome; Sympathetic Nervous System; Time Factors

1983
Clonidine withdrawal complicated by amitriptyline therapy.
    Anesthesiology, 1983, Volume: 59, Issue:1

    Topics: Aged; Amitriptyline; Anxiety; Clonidine; Female; Humans; Hypertension; Intraoperative Care; Methyldopa; Nitroprusside; Postoperative Care; Propranolol; Substance Withdrawal Syndrome; Tachycardia

1983
Drug metabolism and liver function after methyldopa withdrawal.
    British journal of clinical pharmacology, 1980, Volume: 10, Issue:2

    Topics: Age Factors; Aged; Female; Humans; Liver; Liver Function Tests; Methyldopa; Middle Aged; Pharmaceutical Preparations; Substance Withdrawal Syndrome

1980
Blood pressure and heart rate and withdrawal of antihypertensive drugs.
    British medical journal, 1977, May-14, Volume: 1, Issue:6071

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Clonidine; Female; Ganglionic Blockers; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome

1977
Convulsions in mice after anesthesia.
    Anesthesiology, 1979, Volume: 50, Issue:6

    Topics: Anesthetics; Animals; Cyclopropanes; Ether; Ethers; Ethylenes; Humans; Methyldopa; Mice; Mice, Inbred ICR; Nitrous Oxide; Reserpine; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors

1979
[Tardive dyskinesia. Synthetic-critical review and case contribution].
    L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma, 1977, Volume: 48, Issue:1

    Topics: Adult; Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Iatrogenic Disease; Male; Mental Disorders; Methyldopa; Middle Aged; Pyridoxine; Substance Withdrawal Syndrome; Tetrabenazine; Tranquilizing Agents; Valproic Acid

1977
Rebound hypertension after sudden discontinuation of methyldopa therapy.
    The Medical journal of Australia, 1977, Apr-30, Volume: 1, Issue:18

    Topics: Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome

1977
Letter: Rebound hypertension after acute methyldopa withdrawal.
    British medical journal, 1976, Aug-07, Volume: 2, Issue:6031

    Topics: Aged; Female; Humans; Hypertension; Methyldopa; Substance Withdrawal Syndrome

1976
Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy.
    Australian and New Zealand journal of medicine, 1976, Volume: 6, Issue:3 Suppl

    Topics: Animals; Brain; Clonidine; Humans; Hypertension; Male; Methyldopa; Neurons; Substance Withdrawal Syndrome

1976
Evaluation of clonidine hydrochloride (Catapres). A new antihypertensive agent.
    JAMA, 1975, Jul-14, Volume: 233, Issue:2

    Topics: Administration, Oral; Blood Pressure; Cardiac Output; Clonidine; Diuretics; Drug Evaluation; Drug Synergism; Heart Rate; Humans; Hypertension; Injections, Intravenous; Methyldopa; Posture; Substance Withdrawal Syndrome; Vascular Resistance

1975
Rebound hypertension after acute methyldopa withdrawal.
    British medical journal, 1976, May-01, Volume: 1, Issue:6017

    Topics: Aged; Humans; Hypertension; Male; Methyldopa; Substance Withdrawal Syndrome

1976
[Tolerance and withdrawal syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl

    Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antihypertensive Agents; Clonidine; Cyclic AMP; Drug Tolerance; Endorphins; Humans; Methyldopa; Neurotransmitter Agents; Substance Withdrawal Syndrome

1992
Manic syndrome after discontinuation of methyldopa.
    The American journal of psychiatry, 1989, Volume: 146, Issue:8

    Topics: Bipolar Disorder; Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome

1989
Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys.
    Neuropharmacology, 1972, Volume: 11, Issue:2

    Topics: Animals; Behavior, Animal; Brain Chemistry; Caudate Nucleus; Cerebellum; Cerebral Cortex; Dopamine; Haplorhini; Humans; Hypothalamus; Iproniazid; Macaca; Medulla Oblongata; Mesencephalon; Methyldopa; Morphine; Norepinephrine; Pons; Reserpine; Serotonin; Spinal Cord; Substance Withdrawal Syndrome; Substance-Related Disorders; Thalamus; Thebaine

1972
Clonidine in the treatment of severe hypertension.
    The Medical journal of Australia, 1973, Apr-21, Volume: 1, Issue:16

    Topics: Adult; Anesthesia, General; Cerebrovascular Disorders; Clonidine; Coronary Disease; Depression; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney; Male; Methyldopa; Middle Aged; Sexual Behavior; Substance Withdrawal Syndrome

1973
Some pharmacological agents modifying the morphine abstinence syndrome in dogs.
    Archives internationales de pharmacodynamie et de therapie, 1965, Volume: 157, Issue:2

    Topics: Animals; Dihydroxyphenylalanine; Dogs; Drug Tolerance; Humans; Methyldopa; Methyltyrosines; Morphine; Nalorphine; Nialamide; Reserpine; Substance Withdrawal Syndrome

1965